Publication: Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
| dc.contributor.author | Manoon Surabotsophon | en_US |
| dc.contributor.author | Yingyot Klai-On | en_US |
| dc.contributor.author | Vipa Thanachartwet | en_US |
| dc.contributor.author | Sirote Khunapornphairote | en_US |
| dc.contributor.author | Supat Chamnanchanunt | en_US |
| dc.contributor.author | Theerapat Racharak | en_US |
| dc.contributor.author | Wannada Laisuan | en_US |
| dc.contributor.author | Duangjai Sahassananda | en_US |
| dc.contributor.author | Samlee Hapunna | en_US |
| dc.contributor.author | Somjit Jinapuk | en_US |
| dc.contributor.author | Suthee Leelasetakul | en_US |
| dc.contributor.author | Varunee Desakorn | en_US |
| dc.contributor.other | Faculty of Medicine, Ramathibodi Hospital, Mahidol University | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Ramkhamhaeng Hospital | en_US |
| dc.date.accessioned | 2020-12-28T06:03:26Z | |
| dc.date.available | 2020-12-28T06:03:26Z | |
| dc.date.issued | 2020-12-01 | en_US |
| dc.description.abstract | © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. Three patients diagnosed with severe COVID-19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and survived. The thrid patient was diagnosed late and received tocilizumab when the disease progressed to acute respiratory distress syndrome, and died. | en_US |
| dc.identifier.citation | Clinical Case Reports. Vol.8, No.12 (2020), 3264-3277 | en_US |
| dc.identifier.doi | 10.1002/ccr3.3407 | en_US |
| dc.identifier.issn | 20500904 | en_US |
| dc.identifier.other | 2-s2.0-85092529177 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/60534 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092529177&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092529177&origin=inward | en_US |